Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY60.64 CNY
Change Today +1.43 / 2.42%
Volume 4.9M
002252 On Other Exchanges
As of 3:00 AM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

shanghai raas blood produc-a (002252) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/17/15 - CNY65.45
52 Week Low
04/22/14 - CNY28.95
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHANGHAI RAAS BLOOD PRODUC-A (002252)

Related News

No related news articles were found.

shanghai raas blood produc-a (002252) Related Businessweek News

No Related Businessweek News Found

shanghai raas blood produc-a (002252) Details

Shanghai RAAS Blood Products Co., Ltd. is engaged in the research, development, manufacture, and distribution of blood products. The company’s blood products include human serum albumin, intravenous human immunoglobulin (pH4), human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, lyophilized human thrombin, and topical lyophilized fibrin adhesive. It also offers vaccines, diagnostic reagents, testing equipment, and detection technology, as well as provides testing services. The company is based in Shanghai, the People’s Republic of China.

shanghai raas blood produc-a (002252) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shanghai raas blood produc-a (002252) Key Developments

Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter of 2015

Shanghai RAAS Blood Products Co., Ltd. reported earnings results for the first quarter of 2015. For the quarter, the company revealed operating revenue of CNY 356 million, rising 40.1% from a year earlier. Net profit attributable to shareholders reached CNY 379 million, hiking 473.25%.

Shanghai RAAS Blood Products Co., Ltd. Announces 2014 Final Distribution Plan

Shanghai RAAS Blood Products Co., Ltd. announced 2014 final distribution plan for A shares of CNY 1.00000000, to the shareholders register on April 08, 2015. Ex-date will be 09 April 2015. Payment date will be 09 April 2015.

Shanghai RAAS Blood Products Co., Ltd. to Report Q1, 2015 Results on Apr 15, 2015

Shanghai RAAS Blood Products Co., Ltd. announced that they will report Q1, 2015 results on Apr 15, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002252:CH CNY60.64 CNY +1.43

002252 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Beijing Tiantan Biological Products Corp Ltd CNY40.98 CNY +3.02
China Biologic Products Inc $99.62 USD +3.60
Hualan Biological Engineering Inc CNY47.24 CNY +3.84
Jiangxi Boya Bio-Pharmaceutical Co Ltd CNY68.60 CNY +5.80
View Industry Companies

Industry Analysis


Industry Average

Valuation 002252 Industry Range
Price/Earnings 86.4x
Price/Sales 56.9x
Price/Book 9.0x
Price/Cash Flow 98.2x
TEV/Sales 55.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI RAAS BLOOD PRODUC-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at